Patents by Inventor Keith A. Moulton

Keith A. Moulton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240153229
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Application
    Filed: May 1, 2023
    Publication date: May 9, 2024
    Applicant: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, Mark A. BUCKLER, Vladimir VALTCHINOV, David S. PAIK
  • Publication number: 20240093138
    Abstract: Aspects of the present invention relate to an automated cell culture instrument and to methods for operating such an instrument. In one aspect, the cell culture instrument includes a computing unit and a plurality of electrically controllable resources (e.g., sensors, actuators, etc.). The computing unit receives a protocol, schedules the resources so as to execute the protocol, and operates the resources as scheduled or in response to so as to provide an improved environment for cell culture growth. The computing unit may simulate protocol execution in connection with the scheduling or execution of the protocol.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 21, 2024
    Inventors: Howard Cannon, Keith Moulton
  • Publication number: 20240078672
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 7, 2024
    Applicant: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, David S. PAIK
  • Publication number: 20240078671
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 7, 2024
    Applicant: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, David S. PAIK
  • Publication number: 20240078673
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 7, 2024
    Applicant: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, David S. PAIK
  • Patent number: 11884913
    Abstract: Aspects of the present invention relate to an automated cell culture instrument and to methods for operating such an instrument. In one aspect, the cell culture instrument includes a computing unit and a plurality of electrically controllable resources (e.g., sensors, actuators, etc.). The computing unit receives a protocol, schedules the resources so as to execute the protocol, and operates the resources as scheduled or in response to so as to provide an improved environment for cell culture growth. The computing unit may simulate protocol execution in connection with the scheduling or execution of the protocol.
    Type: Grant
    Filed: May 11, 2021
    Date of Patent: January 30, 2024
    Assignee: Thrive Bioscience, Inc.
    Inventors: Howard Cannon, Keith Moulton
  • Publication number: 20230326166
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Application
    Filed: April 26, 2023
    Publication date: October 12, 2023
    Applicant: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, David S. PAIK
  • Publication number: 20230237759
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Application
    Filed: February 8, 2023
    Publication date: July 27, 2023
    Applicant: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, Mark A. BUCKLER, Vladimir VALTCHINOV, David S. PAIK
  • Patent number: 11676359
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Grant
    Filed: May 24, 2021
    Date of Patent: June 13, 2023
    Assignee: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
  • Patent number: 11607179
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Grant
    Filed: May 24, 2021
    Date of Patent: March 21, 2023
    Assignee: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
  • Publication number: 20210390689
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Application
    Filed: May 24, 2021
    Publication date: December 16, 2021
    Applicant: ELUCID BIOIMAGING INC
    Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, Mark A. BUCKLER, Vladimir VALTCHINOV, David S. PAIK
  • Publication number: 20210282719
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Application
    Filed: May 24, 2021
    Publication date: September 16, 2021
    Applicant: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, Mark A. BUCKLER, Vladimir VALTCHINOV, David S. PAIK
  • Patent number: 11120312
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: September 14, 2021
    Assignee: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
  • Patent number: 11113812
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: September 7, 2021
    Assignee: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
  • Publication number: 20210261905
    Abstract: Aspects of the present invention relate to an automated cell culture instrument and to methods for operating such an instrument. In one aspect, the cell culture instrument includes a computing unit and a plurality of electrically controllable resources (e.g., sensors, actuators, etc.). The computing unit receives a protocol, schedules the resources so as to execute the protocol, and operates the resources as scheduled or in response to so as to provide an improved environment for cell culture growth. The computing unit may simulate protocol execution in connection with the scheduling or execution of the protocol.
    Type: Application
    Filed: May 11, 2021
    Publication date: August 26, 2021
    Inventors: Howard Cannon, Keith Moulton
  • Patent number: 11094058
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: August 17, 2021
    Assignee: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
  • Patent number: 11087459
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: August 10, 2021
    Assignee: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
  • Patent number: 11087460
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: August 10, 2021
    Assignee: ELUCID BIOIMAGING INC.
    Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
  • Patent number: 11071501
    Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: July 27, 2021
    Assignee: ELUCID BIOIWAGING INC.
    Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
  • Patent number: 11034929
    Abstract: Aspects of the present invention relate to an automated cell culture instrument and to methods for operating such an instrument. In one aspect, the cell culture instrument includes a computing unit and a plurality of electrically controllable resources (e.g., sensors, actuators, etc.). The computing unit receives a protocol, schedules the resources so as to execute the protocol, and operates the resources as scheduled or in response to so as to provide an improved environment for cell culture growth. The computing unit may simulate protocol execution in connection with the scheduling or execution of the protocol.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: June 15, 2021
    Assignee: Thrive Bioscience, Inc.
    Inventors: Howard Cannon, Keith Moulton